SL
NVO

Salomon & Ludwin’s Novo Nordisk NVO Stock Holding History

Salomon & Ludwin’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Sell
2,189
-484
-18% -$20.8K 0.01% 260
2026
Q1 		$98.8K Buy
2,673
+1,488
+126% +$70.5K 0.01% 253
2025
Q4 		$65.3K Sell
1,185
-300
-20% -$15.3K 0.01% 335
2025
Q3 		$88.6K Buy
1,485
+999
+206% +$58.5K 0.01% 246
2025
Q2 		$33.9K Buy
486
+26
+6% +$1.77K ﹤0.01% 312
2025
Q1 		$31.9K Sell
460
-22
-5% -$1.82K ﹤0.01% 305
2024
Q4 		$41.5K Hold
482
– – ﹤0.01% 263
2024
Q3 		$57.4K Hold
482
– – 0.01% 243
2024
Q2 		$68.8K Sell
482
-130
-21% -$17.2K 0.01% 225
2024
Q1 		$78.6K Buy
612
+202
+49% +$24K 0.01% 286
2023
Q4 		$37.3K Hold
410
– – ﹤0.01% 339
2023
Q3 		$37.3K Buy
+410
New +$36.1K ﹤0.01% 339

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Salomon & Ludwin's NVO Position: Q2 2026 in Review

Salomon & Ludwin reduced its Novo Nordisk (NVO) stake by 18% in Q2 2026, selling an estimated $20.8K and leaving 2,189 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #260.

Salomon & Ludwin first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Salomon & Ludwin held 2,189 shares of Novo Nordisk worth $107K as of Q2 2026.
  • Salomon & Ludwin sold 484 Novo Nordisk shares in Q2 2026, an estimated $20.8K.
  • Novo Nordisk made up 0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #260 holding.
  • Salomon & Ludwin first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.